NeuroBlate System clinical trial for recurrent glioblastoma

Researches have held their first in-human clinical trials of a technology called the NeuroBlate in recurrent glioblastoma multiforme (a type of tumor). The NeuroBlate  uses MRI to guide and scan the laser. This Allows for continual adjustment of the patient's treatment throughout the operation along with real-time thermography. Not only will this increase precision,  but it will also decrease the potential risk for damage to healthy brain tissue.

I chose this article because having a minimally invasive procedure for ablating brain tumors is a big step from the current treatments that are commonly used, in respect to the complications from the procedures. This includes treatments like radiation which has a huge negative affect on the healthy tissue around the tumor.

Article link: http://thejns.org/doi/abs/10.3171/2013.1.JNS1291